Late-stage Genentech trial failures dampen hopes for bowel disease drug By: San Francisco Business Times via Business Journals August 10, 2020 at 17:10 PM EDT The four late-stage clinical trials are part of a six-study set by Genentech in 3,100 inflammatory bowel disease patients. Read More >>
